(Q44577930)

4 December 2017

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy (English)

1 reference

Chronic Thromboembolic Pulmonary Hypertension

4 December 2017

0 references

1 reference

Thorsten Kramm

1

1 reference

4 December 2017

Balthasar Eberle

2

1 reference

4 December 2017

Frank Krummenauer

3

1 reference

4 December 2017

Stefan Guth

4

1 reference

4 December 2017

Hellmut Oelert

5

1 reference

4 December 2017

Eckhard Mayer

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

The Annals of Thoracic Surgery

4 December 2017

1 reference

4 December 2017

76

1 reference

4 December 2017

3

1 reference

4 December 2017

711-718

1 reference

Long-term treatment of pulmonary hypertension with aerosolized iloprost

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Hepatic O2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Chronic thromboembolic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Chronic major-vessel thromboembolic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Pulmonary hypertension in severe acute respiratory failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Placebo and inhaled nitric oxide mortality the same in ARDS clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Nitric oxide improves hypoxaemia following reperfusion oedema after pulmonary thromboendarterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Inhaled iloprost for severe pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Long-term treatment of pulmonary hypertension with aerosolized iloprost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Trials of inhaled iloprost and other new vasodilating prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Medical therapy of pulmonary hypertension. The prostacyclins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

[Severe precapillary pulmonary hypertension in possible antiphospholipid syndrome--partially successful long-term therapy with continuous intravenous iloprost administration. A case report with discussion of new treatment methods]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Stroke in patients with asymptomatic internal-carotid-artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

Postoperative management of the patient undergoing pulmonary thromboendarterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900728-8

10.1016/S0003-4975(03)00728-8

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference